BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31007069)

  • 1. Can Nutritional Status Predict Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer?
    Seo Y; Eo W; Kim S; Shim B; Lee S
    Nutr Cancer; 2019; 71(7):1108-1117. PubMed ID: 31007069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations.
    Park S; Park S; Lee SH; Suh B; Keam B; Kim TM; Kim DW; Kim YW; Heo DS
    Korean J Intern Med; 2016 Nov; 31(6):1140-1149. PubMed ID: 27017943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs.
    Sheng J; Yang YP; Ma YX; Qin T; Hu ZH; Hong SD; Zhou T; Huang Y; Zhao HY; Zhang L
    PLoS One; 2016; 11(1):e0147226. PubMed ID: 26784943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.
    Mitsuyoshi T; Matsuo Y; Itou H; Shintani T; Iizuka Y; Kim YH; Mizowaki T
    J Radiat Res; 2018 Jan; 59(1):50-57. PubMed ID: 29182777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical application value of prognostic nutritional index for predicting survival in patients with advanced non-small cell lung cancer].
    Xu WJ; Kang YM; Zhou L; Chen FF; Song YH; Zhang CQ
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):146-149. PubMed ID: 28219213
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Significance of Prognostic Nutritional Index After Surgical Treatment in Lung Cancer.
    Okada S; Shimada J; Kato D; Tsunezuka H; Teramukai S; Inoue M
    Ann Thorac Surg; 2017 Jul; 104(1):296-302. PubMed ID: 28433217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in older patients with advanced non-small cell lung cancer in China.
    Su Q; Sun YP; Liu YH; Li Z; Yang HY; Sun ZG; Cao BW; Jia JH
    Tumori; 2014; 100(1):69-74. PubMed ID: 24675494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
    Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY
    Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
    Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
    PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Clinical Prognostic Score to Predict Survival of Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Receiving First-Line Chemotherapy: A Retrospective Analysis.
    Gong J; Xu L; Li Z; Hu X; Liu J; Teng Y; Jin B; Zhao M; Shi J; Guo T; Shi X; Cheng Y; Liu Y; Qu X
    Med Sci Monit; 2018 Nov; 24():8264-8271. PubMed ID: 30446633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low pretreatment PNI correlates with worse survival in patients with stage III/IV NSCLC who received chemotherapy.
    Shen Y; Li H; Yuan ZQ; Ren MY; Yu SL; Liao YD; Cai JJ; Liu C; Chen BC; Wu AH; Li GF; Xie L
    Neoplasma; 2020 Mar; 67(2):394-401. PubMed ID: 31847525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.
    Sánchez-Lara K; Turcott JG; Juárez E; Guevara P; Núñez-Valencia C; Oñate-Ocaña LF; Flores D; Arrieta O
    Nutr Cancer; 2012; 64(4):526-34. PubMed ID: 22489794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between nutritional status and prognosis in patients with locally advanced and advanced stage lung cancer.
    Gul B; Metintas S; Ak G; Yilmaz S; Metintas M
    Support Care Cancer; 2021 Jun; 29(6):3357-3365. PubMed ID: 33128137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer.
    Shimizu K; Okita R; Saisho S; Maeda A; Nojima Y; Nakata M
    World J Surg Oncol; 2015 Sep; 13():291. PubMed ID: 26424708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
    Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
    Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
    J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy and survival in advanced non-small cell lung carcinoma: is pneumologists' skepticism justified?].
    Gullón Blanco JA; Suárez Toste I; Fernández Alvarez R; Rubinos Cuadrado G; Medina Gonzálvez A; Galindo Morales R; González Martín IJ
    Arch Bronconeumol; 2006 Jun; 42(6):273-7. PubMed ID: 16827975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective.
    Paralkar VR; Li T; Langer CJ
    Clin Lung Cancer; 2008 Mar; 9(2):116-21. PubMed ID: 18501099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.